Business Context and Reporting Period
This Form 6-K filing by TransAlta Corporation, dated March 2, 2005, reports on the regulatory approval of its normal course issuer bid program. TransAlta is a power generation and wholesale marketing company operating coal-fired, gas-fired, hydro, and renewable facilities in Canada, the U.S., Mexico, and Australia.
Key Financial Metrics
The filing does not provide current period revenue, profit, cash flow, margins, debt, or liquidity figures. The only financial data disclosed relates to share repurchase activity:
- 2004 Repurchases: 143,500 common shares purchased for cancellation.
- Average Price (2004): $16.22 per share.
- Outstanding Shares (as of Feb 15, 2005): 195,114,023.
Material Changes
The primary material change is the renewal of the normal course issuer bid program for the sixth consecutive year. The program authorizes the purchase of up to 3,000,000 common shares for cancellation, representing approximately 1.54% of the outstanding shares as of February 15, 2005.
Guidance, Outlook, and Management Commentary
Program Details:
- Duration: March 4, 2005, to March 3, 2006.
- Method: Purchases will be made on the open market via the Toronto Stock Exchange at market prices. Put options may also be issued to facilitate purchases.
Management emphasizes a low-risk profile maintained through a highly contracted portfolio of assets. The company's focus remains on efficiently operating facilities to provide reliable, low-cost power and creating long-term shareholder value.
Risks and Contingencies: The filing text does not explicitly detail new risks or contingencies beyond the standard operational context.
Key Facts for Investor Verification
- Verify the total number of shares repurchased under the new program once the March 3, 2006, deadline passes.
- Confirm the average price paid for shares repurchased during the 2005-2006 period compared to the 2004 average of $16.22.
- Review subsequent filings for updates on the company's contracted portfolio status and operational performance in Canada, the U.S., Mexico, and Australia.